Home > Insider Trading > Filing (0001209191-21-024238)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1807120	Design Therapeutics Inc.	DSGN	Pharmaceutical Preparations (2834)	823929248

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1848319	Sr One Capital Fund I Aggregator Lp	985 Old Eagle School Road, Suite 511 Wayne PA 19087	No	No	Yes	No
1853723	Sr One Capital Management, Llc	985 Old Eagle School Road, Suite 511 Wayne PA 19087	No	No	Yes	No
1853724	Sr One Capital Partners I, Lp	985 Old Eagle School Road, Suite 511 Wayne PA 19087	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-30	4,439,839	$0.00	4,439,839	No	4	C	Direct
Common Stock	Acquisiton	2021-03-30	936,637	$0.00	5,376,476	No	4	C	Direct
Common Stock	Acquisiton	2021-03-30	250,000	$20.00	5,626,476	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-03-30	7,236,938	$0.00	4,439,839	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-03-30	1,526,718	$0.00	936,637	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

The Series A Preferred Stock and the Series B Preferred Stock were converted into Common Stock on a 1.63-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock and Series B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
SR One Capital Fund I Aggregator, LP purchased 250,000 shares of Common Stock of Design Therapeutics, Inc. (the "Issuer") in connection with the Issuer's public offering.